Huron Consulting Group Inc. (NASDAQ:HURN) is Sunriver Management LLC's 4th Largest Position

Sunriver Management LLC boosted its position in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 10.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 486,597 shares of the business services provider's stock after purchasing an additional 46,968 shares during the period. Huron Consulting Group comprises 7.2% of Sunriver Management LLC's holdings, making the stock its 4th biggest holding. Sunriver Management LLC owned approximately 2.74% of Huron Consulting Group worth $60,465,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in HURN. XTX Topco Ltd purchased a new stake in shares of Huron Consulting Group during the fourth quarter valued at $625,000. Mariner LLC lifted its holdings in Huron Consulting Group by 3.8% during the 4th quarter. Mariner LLC now owns 18,907 shares of the business services provider's stock valued at $2,349,000 after buying an additional 690 shares in the last quarter. Barclays PLC boosted its position in Huron Consulting Group by 10.0% in the 4th quarter. Barclays PLC now owns 37,581 shares of the business services provider's stock valued at $4,671,000 after buying an additional 3,425 shares during the period. Summit Investment Advisors Inc. grew its stake in Huron Consulting Group by 5.5% in the 4th quarter. Summit Investment Advisors Inc. now owns 1,838 shares of the business services provider's stock worth $228,000 after acquiring an additional 96 shares in the last quarter. Finally, Rockefeller Capital Management L.P. grew its stake in Huron Consulting Group by 12.8% in the 4th quarter. Rockefeller Capital Management L.P. now owns 116,446 shares of the business services provider's stock worth $14,470,000 after acquiring an additional 13,219 shares in the last quarter. Institutional investors own 93.90% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on HURN shares. Benchmark reaffirmed a "buy" rating and set a $165.00 target price on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Wedbush upped their target price on Huron Consulting Group from $150.00 to $165.00 and gave the company an "outperform" rating in a research report on Wednesday, March 26th. Truist Financial increased their price objective on shares of Huron Consulting Group from $165.00 to $180.00 and gave the company a "buy" rating in a research report on Tuesday, March 4th. Barrington Research restated an "outperform" rating and set a $167.00 price target on shares of Huron Consulting Group in a research report on Thursday, March 27th. Finally, William Blair reissued an "outperform" rating on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $169.25.

Huron Consulting Group Price Performance

Shares of Huron Consulting Group stock traded up $0.01 during trading hours on Friday, reaching $141.50. 260,828 shares of the company's stock were exchanged, compared to its average volume of 142,811. The company has a market capitalization of $2.54 billion, a P/E ratio of 30.76 and a beta of 0.37. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. Huron Consulting Group Inc. has a 1 year low of $84.26 and a 1 year high of $153.85. The business has a fifty day moving average of $140.98 and a two-hundred day moving average of $127.26.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last issued its earnings results on Tuesday, February 25th. The business services provider reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.38. The company had revenue of $399.31 million during the quarter, compared to analysts' expectations of $380.62 million. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. As a group, research analysts predict that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

Insider Activity at Huron Consulting Group

In other news, Director James H. Roth sold 2,000 shares of the business's stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $126.03, for a total value of $252,060.00. Following the sale, the director now directly owns 48,534 shares of the company's stock, valued at approximately $6,116,740.02. The trade was a 3.96 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John Mccartney sold 500 shares of Huron Consulting Group stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $151.13, for a total transaction of $75,565.00. Following the completion of the sale, the director now owns 55,688 shares of the company's stock, valued at $8,416,127.44. This trade represents a 0.89 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 78,781 shares of company stock worth $11,484,452. Insiders own 2.02% of the company's stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.